Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Bibliografische gegevens
Hoofdauteurs:	Bottomley, M, Chen, M, Fuggle, S, Harden, P, Wood, K
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Lippincott, Williams and Wilkins 2016

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
door: Ramon M. Rodriguez, et al.
Gepubliceerd in: (2021-08-01)

Update on the long-term complications of renal transplantation.
door: Bottomley, M, et al.
Gepubliceerd in: (2013)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
door: Bottomley, M, et al.
Gepubliceerd in: (2022)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
door: Mysore K. Phanish, et al.
Gepubliceerd in: (2020-03-01)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
door: Bittar, A, et al.
Gepubliceerd in: (1990)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
door: Bottomley, MJ, et al.
Gepubliceerd in: (2022)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
door: Procter, J, et al.
Gepubliceerd in: (2009)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
door: I G Rekhtina, et al.
Gepubliceerd in: (2008-07-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
door: Matthew J. Bottomley, et al.
Gepubliceerd in: (2022-07-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
door: Sh. R. Galeev, et al.
Gepubliceerd in: (2020-07-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
door: Procter, J, et al.
Gepubliceerd in: (2009)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
door: Ratcliffe, P, et al.
Gepubliceerd in: (1996)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
door: Alessandro C. Rosa, et al.
Gepubliceerd in: (2023-10-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
door: Alfonso J. Rodriguez-Morales, et al.
Gepubliceerd in: (2017-04-01)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
door: Bottomley, M
Gepubliceerd in: (2015)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
door: Katherine A. Barraclough, et al.
Gepubliceerd in: (2011-01-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
door: Lally, A, et al.
Gepubliceerd in: (2006)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
door: Rahbaninobar Mohammad, et al.
Gepubliceerd in: (2004-09-01)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
door: Noa Scott, et al.
Gepubliceerd in: (2023-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
door: Cvetković Tatjana, et al.
Gepubliceerd in: (2015-01-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
door: Muduma G, et al.
Gepubliceerd in: (2014-11-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
door: Iqbal A, et al.
Gepubliceerd in: (2000-01-01)

Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.
door: Jacek Pliszczynski, et al.
Gepubliceerd in: (2020-09-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
door: Brook, MO, et al.
Gepubliceerd in: (2022)

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
door: Sofia Christakoudi, et al.
Gepubliceerd in: (2020-08-01)

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature
door: Joyita Bharati, et al.
Gepubliceerd in: (2021-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
door: Koen G. A. M. Hussaarts, et al.
Gepubliceerd in: (2021-01-01)

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
door: Knight, S, et al.
Gepubliceerd in: (2016)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
door: Kentaro Ide, et al.
Gepubliceerd in: (2011-01-01)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients
door: Pengpeng Zhang, et al.
Gepubliceerd in: (2021-05-01)

Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection
door: Amitabh Jha, et al.
Gepubliceerd in: (2018-01-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
door: Susan Dutton, et al.
Gepubliceerd in: (2022-04-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
door: Ohe, H, et al.
Gepubliceerd in: (2011)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
door: Jade M Kozuch, et al.
Gepubliceerd in: (2024-12-01)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
door: Catherine Zilberg, et al.
Gepubliceerd in: (2022-05-01)

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
door: Andreas Krisl, et al.
Gepubliceerd in: (2020-12-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
door: Dagmara Szypulska-Koziarska, et al.
Gepubliceerd in: (2021-07-01)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
door: V. Ram Peddi, MD, et al.
Gepubliceerd in: (2023-02-01)

Predictors of cancer risk in the long-term solid-organ transplant recipient.
door: Sherston, SN, et al.
Gepubliceerd in: (2014)

Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
door: Jennifer Felicia Scheel, et al.
Gepubliceerd in: (2018-02-01)

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Gelijkaardige items

Gelijkaardige items